I maybe wrong as only going on what I have learnt from our forum, but my understanding is this.
With out trial final stage, I believe we got the type of patient who were already too far down the line, as other trials took the type of patient we were having so much success with. So as with our initial phases, it works. I bet when given earlier as they were next looking to do, it will stop disease progression. Major breakthrough when you consider that at any time a different vaccine beating new strain could emerge.
would be grateful if someone could let me know if these cells are part of our patent protected area.
I take this as good news.
regards
Yelrom
I maybe wrong as only going on what I have learnt from our...
-
- There are more pages in this discussion • 9,538 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.045(4.00%) |
Mkt cap ! $1.335B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.18 | $1.13 | $4.980M | 4.315M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 73090 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 27903 | 1 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |